Market
GE HealthCare raises 2026 outlook after positive Q3
GE HealthCare raised its 2026 outlook following strong third-quarter results, driven partly by growth in its PDx (precision diagnostics) segment. The company recently bolstered PDx with a $945 million acquisition of SOFIE Biosciences, a move intended to expand its precision diagnostics capabilities and market position.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network